Anzeige
Mehr »
Login
Montag, 11.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Breaking News: Das geheime Potenzial von 55?$ pro Aktie in einem Clean-Energy-Deal!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A402TW | ISIN: US88165K1016 | Ticker-Symbol: G28
Tradegate
08.11.24
21:48 Uhr
1,120 Euro
-0,020
-1,75 %
1-Jahres-Chart
TEVOGEN BIO HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
TEVOGEN BIO HOLDINGS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,1801,28008.11.

Aktuelle News zur TEVOGEN BIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrTevogen Bio Inc: Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations35WARREN, N.J., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio ("Tevogen" or "Tevogen Bio Holdings Inc.") (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically...
► Artikel lesen
MiTevogen Bio partners Microsoft for HPV treatment11
DiTevogen Bio Inc: Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company's Novel Business Model as Key to Sustainable Success through Patient Affordability2
DiTevogen Bio Inc: Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 9203
04.11.Tevogen Bio Inc: Tevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient Support2
31.10.Tevogen partners with Microsoft to speed up drug development8
31.10.Tevogen kooperiert mit Microsoft zur Beschleunigung der Medikamentenentwicklung9
31.10.Tevogen Bio Inc: Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs4
29.10.Tevogen Bio Inc: Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company111Regained compliance without effecting a reverse stock splitTevogen Bio CEO reaffirms his commitment to preserve shareholder value WARREN, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio ("Tevogen"...
► Artikel lesen
29.10.Tevogen Bio plans new R&D and manufacturing facility3
29.10.Tevogen Bio Inc: Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity81CD8 Technology Services, LLC ("CD8 Technology") to provide turn-key facility for Tevogen BioReinforces Tevogen Bio's commitment to preserving shareholder valueExpected to further enhance Tevogen Bio's...
► Artikel lesen
25.10.Tevogen Bio Inc: Tevogen Bio Provides Additional Guidance on Introduction of T Cell Therapy for Oncology and Specialty Care Therapeutic Areas159WARREN, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio ("Tevogen" or "Tevogen Bio Holdings Inc.") (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically...
► Artikel lesen
24.10.HotStocks USA: + 30 % bei Tevogen Bio7
24.10.Pre-market Movers: CCSC Technology International, Orangekloud Technology, ZenaTech, Tevogen Bio, QuantumScape480OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.30 A.M. ET).In the Green CCSC Technology International Holdings Limited (CCTG)...
► Artikel lesen
23.10.Tevogen Bio Shares Are Soaring Wednesday: What's Going On? 13
23.10.Tevogen Bio Inc: Tevogen Bio's Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development20
22.10.Tevogen Bio Inc: Tevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This Week60WARREN, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio ("Tevogen" or "Tevogen Bio Holdings Inc.") (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically...
► Artikel lesen
21.10.Tevogen Bio Inc: Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion90Treatment of a subgroup of patients with post-acute sequelae of SARS-CoV-2.Forecast adds to Tevogen Bio's Oncology therapeutic area projections of $1 billion in the launch year and $10-$14 billion...
► Artikel lesen
21.10.Tevogen Bio Inc: Tevogen Bio Provides Clarity on CSO Share Sales to Satisfy Tax Obligations, Expects Additional Forecast and Progress Updates in the Coming Days2
19.10.Wissenschaftlicher Leiter von Tevogen Bio Holdings verkauft Aktien im Wert von 1,75 Millionen US-Dollar17
Seite:  Weiter >>
82 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1